One of the most powerful tools in modern oncology is Genetic Testing. While most cancers (90-95%) are "sporadic" (caused by aging, lifestyle, or environment), about 5-10% are "hereditary." This means a specific gene mutation—a glitch in the DNA code—is passed down from parent to child, significantly maximizing the risk of developing certain cancers.
Genetic testing allows us to see these potential threats years before cancer develops, offering the ultimate form of prevention.
"Your genes are not your destiny. Knowing your genetic risk is empowering—it shifts the power from the disease to the patient."
Patients are often confused between two types of DNA tests:
| Feature | Germline Testing | Somatic (Tumor) Testing |
|---|---|---|
| What is tested? | Healthy cells (Blood or Saliva) | Tumor tissue (Biopsy) |
| What it looks for? | Inherited mutations from parents | Acquired mutations in the tumor |
| Purpose | Assess risk for you & family | Select targeted therapy drugs |
| Example | BRCA1 test for breast cancer risk | EGFR test for Lung cancer drugs |
There are many hereditary syndromes, but the most common ones include:
Caused by mutations in BRCA1 and BRCA2 genes.
Risks: High risk of breast and ovarian cancer in women; prostate and
breast cancer in men; pancreatic cancer in both.
Caused by mutations in genes like MLH1, MSH2, MSH6, PMS2.
Risks: Colorectal, Endometrial (Uterine), Stomach, and Ovarian cancers.
Li-Fraumeni Syndrome (TP53): High risk of soft tissue sarcomas and brain
tumors.
Cowden Syndrome (PTEN): Thyroid, breast, and uterine risks.
Testing is simple but psycho-socially complex. It involves:
Results are not just "Yes" or "No." They can be:
A negative result is good news, but it doesn't always mean "zero risk."
Science is advancing rapidly. Soon, we may not need tissue biopsies. Liquid Biopsies allow us to detect cancer DNA circulating in the blood. This non-invasive method is already being used to monitor treatment response and is being researched for early detection.
If you test positive, your first-degree relatives (siblings, children, parents) have a 50% chance of having the same mutation. Testing them is called "Cascade Testing." It saves lives by catching high-risk individuals before they ever get cancer.
It is not just a blood test; it is a process. Here is what to expect with Dr. Aswin's team:
Genetic testing sounds expensive, but costs have dropped significantly (from lakhs to thousands). Many insurance plans now cover testing if there is a strong family history. We can help you navigate the paperwork.
Waiting for genetic results is stressful. Remember:
| Gene | Associated Syndrome | Primary Risks |
|---|---|---|
| BRCA1 / BRCA2 | HBOC Syndrome | Breast, Ovarian, Prostate, Pancreatic |
| MLH1 / MSH2 | Lynch Syndrome | Colon, Uterine, Stomach |
| TP53 | Li-Fraumeni | Sarcoma, Brain, Breast, Adrenal |
| CDH1 | Hereditary Diffuse Gastric Cancer | Stomach (Diffuse type), Lobular Breast Ca |
| PALB2 | - | Similar to BRCA2 (Breast, Pancreas) |
In India, currently, insurance companies cannot cancel an existing policy based on genetic results. Is buying a new policy, you must disclose it if asked. However, testing positive helps you get preventive coverage (like screening MRI scans) which might otherwise be denied.
We use only NABL/CAP accredited labs that follow strict data privacy laws (HIPAA/GDPR compliant). Your data is de-identified and used only for your clinical report.